查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564069

心肺自動輸血系統的全球市場

Cardiopulmonary Autotransfusion Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球心肺自動輸血系統市場預計將達到7.596億美元

心肺自動輸血系統的全球市場預計2023年為6.538億美元，預計2030年將達到7.596億美元，2023-2030年分析期間複合年成長率為2.2%。體外循環輸血設備是本報告分析的細分市場之一，預計複合年成長率為 2.4%，到分析期結束時將達到 5.238 億美元。在分析期間，非體外循環輸血裝置領域的複合年成長率預計為 1.7%。

美國市場預估為1.759億美元，中國預期複合年成長率為1.7%

2023年美國心肺自動輸血系統市場預估為1.759億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到1.18億美元，2023-2030年分析期間複合年成長率為1.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.2% 和 1.4%。在歐洲，德國的複合年成長率預計為 1.6%。

全球心肺自動輸血系統市場－主要趨勢與促進因素總結

心肺自動輸血系統為手術中的血液管理帶來了什麼樣的革命？

心肺自動輸血系統允許患者在手術過程中收集和重複使用自己的血液，在現代外科手術中發揮重要作用。這種系統在經常流失大量血液的手術中尤其重要，例如心血管手術手術或創傷手術。傳統上，輸血依賴捐血，但這種方法有感染疾病、免疫反應和血液短缺等風險。自體輸血系統透過在手術期間收集、過濾和回輸患者自己的血液來緩解這些問題。這不僅減少了對捐血的需求，也降低了與輸血反應相關的風險。此外，這些系統可確保患者獲得更新鮮、更相容的血液，從而縮短恢復時間並降低術後併發症的可能性。在心肺手術中，有效管理失血至關重要，自動輸血系統對於維持患者穩定性和減少醫療保健系統中對捐血的整體需求至關重要。

科技如何改善心肺自動輸血系統？

技術進步顯著提高了心肺自動輸血系統的效率和可靠性，使其能夠更有效地控制術中出血。最新的自動化輸血機採用先進的過濾和分離技術，以確保更高品質的回輸。這些系統可以有效地將紅血球與脂肪、骨頭碎片和血塊等污染物分離，只允許過濾後的潔淨血液回流到病人體內。此外，新系統更加緊湊且方便用戶使用，可以更快地設定並更輕鬆地整合到手術工作流程中。這些設備的便攜性意味著它們可以在從大型心血管手術到創傷中心的各種環境中使用，而無需笨重的固定設備。此外，自動化處理系統的引入減少了所需的體力勞動，最大限度地減少了人為錯誤的可能性，並提高了自動化輸血過程的安全性和可靠性。許多現代系統還包括即時監控和資料收集功能，使手術團隊能夠在整個手術過程中追蹤血液量和質量，以確保最佳的患者治療效果。這些創新顯著提高了自動化輸血系統在複雜手術期間提供安全高效血液管理的能力。

什麼趨勢正在塑造心肺自動輸血系統市場？

幾個關鍵趨勢正在影響心肺自動輸血系統市場的成長和開拓，反映了醫療保健實踐和手術技術的更廣泛轉變。一個主要趨勢是越來越關注患者安全並減少與同種異體輸血相關的併發症。隨著人們對與捐贈者輸血相關的風險（例如感染疾病和免疫反應）的認知不斷提高，越來越多的醫療保健提供者正在採用自動輸血系統作為更安全的替代方案。此外，捐贈者血液供不應求以及與血液儲存和輸血相關的高成本增加了手術環境中對血液儲存技術的需求。向微創手術的轉變也正在影響市場。儘管這些手術侵入性較小，但由於出血風險，它們仍然需要有效的血液管理系統。這一趨勢導致了更小、更便攜的自體輸血設備的開發，這些設備可以適應各種手術環境。此外，隨著世界各地的醫療保健系統越來越注重降低醫療成本，自動輸血系統作為一種具有成本效益的解決方案越來越受到關注。透過減少對昂貴捐血的需求並最大限度地減少術後併發症，這些系統可以幫助醫院更有效地管理資源，同時改善患者的治療效果。

推動心肺自動輸血系統市場成長的關鍵因素是什麼？

技術進步、病人安全意識的提高以及對高效血液管理解決方案的需求不斷增加共同推動了心肺自動輸血系統市場的成長。主要促進因素之一是人們對同種異體輸血的安全性日益關注，這種輸血可能帶來感染疾病、過敏反應和免疫抑制等風險。隨著醫療保健提供者優先考慮患者安全，自動輸血系統的採用不斷增加，提供了安全的替代方案，可以最大限度地降低這些風險。另一個重要的促進因素是捐血成本上升和稀缺，特別是在血液供應基礎設施有限的地區。自體輸血系統透過重複使用患者自己的血液、減少對捐血的依賴並降低整體醫療保健成本，提供了一種經濟高效的解決方案。技術進步也在市場擴張中發揮重要作用。現代自體輸血系統是複雜外科手術的首選，尤其是心臟、整形外科和創傷病例，因為它們更有效、更容易使用，並且可以實現更高品質的回輸。微創手術的日益普及進一步增加了對緊湊型攜帶式可攜式輸血系統的需求，這些系統可以無縫整合到各種手術環境中。此外，醫療保健提供者越來越關注血液保護策略，以改善資源管理，而自動輸血系統被認為是這方面的有效工具。此外，監管機構和醫療機構正在推廣包括自動輸血在內的血液管理通訊協定，進一步推動這些系統在醫院和外科中心的採用。這些綜合因素預計將在未來幾年繼續推動心肺自動輸血系統市場的成長。

受訪企業範例（12家知名企業）

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation-Terumo Interventional Systems

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10901

Global Cardiopulmonary Autotransfusion Systems Market to Reach US$759.6 Million by 2030

The global market for Cardiopulmonary Autotransfusion Systems estimated at US$653.8 Million in the year 2023, is expected to reach US$759.6 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end of the analysis period. Growth in the Off-Pump Transfusion Device segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$175.9 Million While China is Forecast to Grow at 1.7% CAGR

The Cardiopulmonary Autotransfusion Systems market in the U.S. is estimated at US$175.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$118.0 Million by the year 2030 trailing a CAGR of 1.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 1.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Cardiopulmonary Autotransfusion Systems Market - Key Trends and Drivers Summarized

How Are Cardiopulmonary Autotransfusion Systems Revolutionizing Blood Management in Surgery?

Cardiopulmonary autotransfusion systems play a crucial role in modern surgical procedures by allowing patients to recover and reuse their own blood during surgery. These systems are particularly essential in cardiac and trauma surgeries, where significant blood loss is common. Traditionally, blood transfusions have relied on donor blood, but this approach carries risks such as infections, immune reactions, and blood shortages. Autotransfusion systems mitigate these issues by collecting, filtering, and reinfusing the patient’s own blood during the surgical procedure. This not only reduces the need for donor blood but also decreases the risks associated with transfusion reactions. Additionally, these systems ensure that patients receive fresher and more compatible blood, improving recovery times and reducing the likelihood of postoperative complications. In the context of cardiopulmonary surgeries, where managing blood loss efficiently is paramount, autotransfusion systems have become indispensable in maintaining patient stability and reducing the overall demand for donor blood in the healthcare system.

How Has Technology Improved Cardiopulmonary Autotransfusion Systems?

Technological advancements have significantly enhanced the efficiency and reliability of cardiopulmonary autotransfusion systems, making them more effective in managing intraoperative blood loss. Modern autotransfusion devices are now equipped with advanced filtration and separation technologies that ensure higher-quality blood reinfusion. These systems can effectively separate red blood cells from contaminants like fat, bone fragments, and clots, ensuring that only clean, filtered blood is returned to the patient. Additionally, newer systems are more compact and user-friendly, allowing for faster setup and easier integration into surgical workflows. The portability of these devices means they can be used in a variety of settings, from major cardiac surgeries to trauma centers, without the need for large, stationary machines. Furthermore, the introduction of automated processing systems has reduced the manual intervention required, minimizing the chance of human error and improving the safety and reliability of the autotransfusion process. Many of the latest systems also feature real-time monitoring and data collection capabilities, which allow surgical teams to track blood volume and quality throughout the procedure, ensuring optimal patient outcomes. These technological innovations have greatly improved the ability of autotransfusion systems to provide safe, efficient blood management during complex surgeries.

What Trends Are Shaping the Cardiopulmonary Autotransfusion Systems Market?

Several key trends are influencing the growth and development of the cardiopulmonary autotransfusion systems market, reflecting broader shifts in healthcare practices and surgical technologies. One major trend is the increasing emphasis on patient safety and the reduction of complications related to allogeneic blood transfusions. As awareness of the risks associated with donor blood transfusions, such as infections and immune reactions, grows, more healthcare providers are adopting autotransfusion systems as a safer alternative. Additionally, there is a rising demand for blood conservation techniques in surgical settings, driven by shortages in donor blood supplies and the high costs associated with blood storage and transfusion. The shift towards minimally invasive surgeries is also impacting the market, as these procedures, although less invasive, still require efficient blood management systems due to the risk of bleeding. This trend has led to the development of smaller, more portable autotransfusion devices that are adaptable to a range of surgical environments. Moreover, as healthcare systems worldwide place increasing importance on reducing healthcare costs, autotransfusion systems are gaining traction as a cost-effective solution. By reducing the need for expensive donor blood and minimizing postoperative complications, these systems help hospitals manage resources more efficiently while improving patient outcomes.

What Are the Major Factors Driving Growth of the Cardiopulmonary Autotransfusion Systems Market?

The growth in the cardiopulmonary autotransfusion systems market is driven by a combination of technological advancements, increased awareness of patient safety, and the rising demand for efficient blood management solutions. One of the primary drivers is the growing concern over the safety of allogeneic blood transfusions, which can carry risks such as infections, allergic reactions, and immune suppression. As healthcare providers prioritize patient safety, the adoption of autotransfusion systems is increasing, offering a safer alternative that minimizes these risks. Another significant driver is the rising cost and shortage of donor blood, particularly in regions with limited blood supply infrastructure. Autotransfusion systems provide a cost-effective solution by recycling the patient’s own blood, reducing the dependency on donor blood and lowering overall healthcare costs. Advancements in technology have also played a major role in expanding the market. Modern autotransfusion systems are more efficient, user-friendly, and capable of delivering higher-quality blood reinfusion, making them a preferred choice in complex surgeries, especially in cardiac, orthopedic, and trauma cases. The growing popularity of minimally invasive surgeries has further increased the demand for compact, portable autotransfusion systems that can be seamlessly integrated into different surgical environments. Additionally, healthcare providers are increasingly focused on blood conservation strategies to improve resource management, and autotransfusion systems are seen as an effective tool in this regard. Moreover, regulatory bodies and healthcare organizations are promoting blood management protocols that include autotransfusion, further driving the adoption of these systems across hospitals and surgical centers. These combined factors are expected to continue fueling the growth of the cardiopulmonary autotransfusion systems market in the coming years.

Select Competitors (Total 12 Featured) -

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation -Terumo Interventional Systems

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiopulmonary Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Minimally Invasive Surgery Propel Growth of Cardiopulmonary Autotransfusion Systems
    • Aging Population and Increased Cardiovascular Procedures Spur Demand for Autotransfusion Technologies
    • Rising Concerns over Blood Safety and Infection Risks Strengthen the Business Case for Autotransfusion Systems
    • Increased Adoption of Enhanced Filtration Technologies Drives Penetration of Next-Generation Autotransfusion Systems
    • Focus on Blood Conservation in Surgical Procedures Propels Adoption of Autotransfusion Devices
    • Integration of Advanced Monitoring and AI in Autotransfusion Systems Drives Technological Innovation
    • Growing Popularity of Outpatient and Ambulatory Surgical Centers Expands Opportunities for Portable Autotransfusion Systems
    • Surge in Complex Cardiovascular Surgeries Generates Demand for High-Capacity Autotransfusion Devices
    • Here's How Remote Monitoring Capabilities in Autotransfusion Systems Are Transforming Post-Surgical Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiopulmonary Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for On-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Off-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION